Phaarmasia Ltd is engaged in manufacturing and marketing of Cosmetics, Oral Contraceptive Pills (OCP) and Combipack with Iron TabletsBusiness Overview: Company provides various therapeutic dosage combinations for Ministry of Health & Family Welfare and also for exports. In FY20, company became a Sick Industrial Company under SICA and was referred...
Phaarmasia Ltd. has released its reviewed financial results for the quarter ended June 30, 2025. The Board of Directors considered and approved these results. For the quarter, the company reported a Revenue from Operations of Rs 6.87 Cr and a Net Profit of Rs 0.27 Cr. Earnings per share stood...
Phaarmasia Ltd. has publicly released its unaudited financial results for the quarter ended June 30, 2025, providing a key update for retail investors. The company reported a total income from operations of Rs. 1.79 Cr and a net profit after tax of Rs. 1.46 Cr. Earnings per share for the...
Phaarmasia Ltd. has announced a certificate from its Registrar and Share Transfer Agent confirming that securities received for dematerialisation have been duly verified, mutilated, and cancelled. The ownership records with the depositories NSDL and CDSL have been updated within the stipulated timeframe, and the details have been reported to the...
Phaarmasia Ltd. has announced a board meeting to consider the financial results for the quarter and half-year. The company reported total income of ₹3125.49 lakh and a net loss before tax of ₹54.59 lakh for the year ended March 31, 2025. Net profit before tax after exceptional items stood at...
Phaarmasia Ltd. has announced a board meeting to discuss regulatory compliance, specifically noting that their Registrar and Share Transfer Agent has confirmed adherence to SEBI regulations regarding the dematerialization of securities for the quarter ending 31st March 2025. This certification ensures that all received securities have been verified, mutilated, and...
